According to the latest report by IMARC Group, titled “Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027â€, the global viral inactivation market size reached US$ 517.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,018.1 Million by 2027, exhibiting a growth rate (CAGR) of 11.7% during 2022-2027.
Market Outlook:
A virus is a type of infectious particle that invades cells and proliferates, resulting in various diseases. Viral inactivation is one of the first steps designed to enhance the efficacy and safety of biotherapeutic products. It helps stop the viruses in a given sample from contaminating the product by rendering them non-infectious or eliminating their presence entirely. The technique is widely used in the blood plasma in the food industries to prevent the presence of viral particles. Currently, several methods of viral inactivation are available in the market, depending on the various characteristics of the virus and the type of biotherapeutic product.
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Request Free Report Sample: https://www.imarcgroup.com/viral-inactivation-market/requestsample
The global viral inactivation market is primarily driven by the rising number of chronic diseases, such as cancer, autoimmune diseases, and diabetes. In line with this, governments of various nations are heavily investing in the advancement of the healthcare industry. They are also introducing stringent regulatory standards in the development of biotherapeutic products at an early stage, which is providing a considerable boost to the market growth.
Moreover, the surging concerns about the transmission of blood-borne viruses and the increasing investments in research and development (R&D) activities are boosting the market growth. Additionally, key players are developing new physical methods, such as gas plasma, supercritical fluids, and pulsed electric fields, to increase the suitability, reliability, and convenience of viral inactivation, which is accelerating the market growth.
Viral Inactivation Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global viral inactivation market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Players Included in Global Viral Inactivation Market Research Report:
Charles River Laboratories (NYSE: CRL)
Merck KGaA
Parker Hannifin Corp
Rad Source Technologies
Sartorius AG
SGS SA
Terumo Corporation
Texcell
Vironova AB
WuXi AppTec
Key Market Segmentation:
The report has segmented the global viral inactivation market on the basis of product, application, end use and region.
Breakup by Product:
Reagents and Kits
Systems
Services
Breakup by Application:
Vaccines and Therapeutics
Stem Cell Products
Blood and Blood Products
Tissue and Tissue Products
Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Others
Geographical Analysis:
North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4115&flag=C
Key Highlights of the Report:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
Market Performance (2016-2021)
Market Outlook (2022-2027)
Industry Trends
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us                                   Â
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
